Department of Nephrology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, China.
Chin Med J (Engl). 2017 Sep 20;130(18):2251-2256. doi: 10.4103/0366-6999.213965.
: In the upcoming era of precision medicine, searching for the early, noninvasive biomarkers has been the cornerstone and major challenge in the management of chronic kidney disease (CKD). Urine contains rich biological information which could be the ideal source for noninvasive biomarkers of CKD. This review will discuss the recent advance in urinary biomarker.
: This review was based on data in articles published in the PubMed databases up to June 20, 2017, with the following keywords: "Chronic kidney disease", "Biomarker", and "Urine".
: Original articles and important reviews on urinary biomarker were selected for this review.
: Urinary biomarker studies of CKD mainly focused on urine sediment, supernatant, and urinary extracellular vesicles. The gene transcript (microRNA [miRNA], messenger RNA [mRNA]) biomarkers have been recently shown with diagnostic potential for CKD reflecting kidney function and histological change. However, challenges regarding technique and data analysis need to be resolved before translation to clinic.
: Different fractions of urine contain rich information for biomarker discovery, among which urine (extracellular vesicles) mRNA, miRNA, might represent promising biomarker for CKD.
在精准医学的时代,寻找早期、非侵入性的生物标志物已成为慢性肾脏病(CKD)管理的基石和主要挑战。尿液中含有丰富的生物学信息,可能是 CKD 无创生物标志物的理想来源。本文将讨论尿液生物标志物的最新进展。
本综述基于截至 2017 年 6 月 20 日在 PubMed 数据库中发表的文章中的数据,使用以下关键词:“慢性肾脏病”、“生物标志物”和“尿液”。
选择了关于尿液生物标志物的原始文章和重要综述进行本综述。
CKD 的尿液生物标志物研究主要集中在尿沉渣、上清液和尿液细胞外囊泡上。基因转录物(microRNA [miRNA]、信使 RNA [mRNA])生物标志物最近已显示出对反映肾功能和组织学变化的 CKD 具有诊断潜力。然而,在转化为临床应用之前,需要解决技术和数据分析方面的挑战。
尿液的不同成分包含丰富的生物标志物发现信息,其中尿液(细胞外囊泡)mRNA、miRNA 可能是 CKD 有前途的生物标志物。